Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roflumilast effects on cognition and EEG in healthy adults
NL-OMON36123Phase 3Active, not recruiting
- Sponsor
- Maastricht University
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of roflumilast, sponsored by Maastricht University. Started Nov 2011; status: active, not recruiting.
02
Drugs
roflumilast
Beyond the preview
Go deeper on NL-OMON36123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36123.